2024
DOI: 10.1177/0976500x241240643
|View full text |Cite
|
Sign up to set email alerts
|

Ustekinumab: In Psoriasis and Beyond —A Derm atological Perspective

Aditya Kumar Bubna,
Vinayak Viplav

Abstract: Background: Ustekinumab is an interleukin 12/23 inhibitor, approved by the US-FDA for the management of moderate-to-severe plaque psoriasis and psoriatic arthropathy. Purpose: This review aims to describe the dermatological implications and applications of ustekinumab. Methods: PubMed and Google Scholar were searched for scholarly articles related to ustekinumab and its utility in dermatology using the search terms “Ustekinumab” AND “Psoriasis” AND “dermatological diseases”. Studies utilising Ustekinumab in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 124 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?